
BioDelivery is a pharmaceutical company that primarily focuses on developing medicines for pain management and addiction... Read more
BioDelivery is a pharmaceutical company that primarily focuses on developing medicines for pain management and addiction... Read more
Followers on Owler
69
Followers on Owler
CEO
Herm Cukier
OVERVIEW
Founded:
1997
Headquarters:
RaleighNorth Carolina
Status:
PublicIndependent Company of NASDAQBDSI
Industry Sector:
SIC Code:
8000NAICS listing »
Flexion Therapeutics is seen as one of BDSI's biggest rivals. Flexion Therapeutics is headquartered in Burlington, Massachusetts, and was founded in 2007. Flexion Therapeutics competes in the Pharmaceuticals field. Flexion Therapeutics generates 60% the revenue of BDSI.
Annual Revenue
$97.8M
BDSI's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 487.1M. Over the last four quarters, BDSI's revenue has grown by 68.1%. Specifically, in Q3 2019's revenue was $30.3M; in Q2 2019, it was $29.7M; in Q1 2019, it was $19.8M; in Q4 2018, BDSI's revenue was $18M.
No recent acquisitions found related to BDSI
Since BDSI was founded in 1997, it has participated in 5 rounds of funding. In total BDSI has raised $105.5M. BDSI's last funding round was on May 2018 for a total of $50.0M
Since BDSI was founded in 1997, it has participated in 5 rounds of funding. In total BDSI has raised $105.5M. BDSI's last funding round was on May 2018 for a total of $50.0M
No recent investments found related to BDSI
BDSI currently has 278 followers on Twitter. As of September 2015 BDSI had 129 followers. That's a 115 percent increase in 2 years
BDSI currently has 1,593 fans on Facebook. As of July 2013 BDSI had 6 fans. That's a 26450 percent increase in 6 years